Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
9.00
-0.04 (-0.50%)
May 7, 2025, 4:00 PM EDT - Market closed
Pharming Group Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Pharming Group stock have an average target of 30, with a low estimate of 14 and a high estimate of 39. The average target predicts an increase of 233.33% from the current stock price of 9.00.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 21, 2025.
Analyst Ratings
The average analyst rating for Pharming Group stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +311.11% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +311.11% | Mar 20, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $30 → $39 | Buy | Maintains | $30 → $39 | +333.33% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +311.11% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $37 | Strong Buy | Reiterates | $37 | +311.11% | Dec 17, 2024 |
Financial Forecast
Revenue This Year
334.03M
from 297.20M
Increased by 12.39%
Revenue Next Year
366.89M
from 334.03M
Increased by 9.84%
EPS This Year
0.02
from -0.02
EPS Next Year
-0.02
from 0.02
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 352.6M | 411.3M | 477.5M | ||
| Avg | 334.0M | 366.9M | 396.5M | ||
| Low | 305.8M | 306.5M | 266.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 18.6% | 23.1% | 30.2% | ||
| Avg | 12.4% | 9.8% | 8.1% | ||
| Low | 2.9% | -8.2% | -27.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.16 | 0.02 | 0.07 | ||
| Avg | 0.02 | -0.02 | 0.03 | ||
| Low | -0.04 | -0.06 | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | -10.5% | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.